Migraine is currently understood as a complex, variable disorder of nervous system function, rather than simply a vascular headache. For most patients, it is a lifelong condition with variable expression over time. Patients with migraine often experience significant disability. In recent years, new pharmacologic strategies for migraine have emerged that address some of the challenges associated with conventional therapies. These include agents that target calcitonin gene-related peptide (CGRP), a neuropeptide central to migraine pathophysiology that has been observed to increase during a migraine. This program addresses the pathophysiology of migraine and the role of the CGRP pathway; diagnosis and treatment of acute migraine; treatments to prevent migraine, including anti-CGRP therapies; and how to integrate CGRP inhibitors into clinical practice.
eNewsletter with interactive benchmarking and audio commentary
After completing this activity, participants should be better able to:
- Describe the benefits and limitations of conventional acute and preventive therapies in patients with migraine
- Summarize the role of the CGRP pathway in migraine pathophysiology and how CGRP inhibitors impact this pathway
- Identify therapy-specific and patient factors to consider when evaluating the use of novel CGRP inhibitors for the acute and preventive treatment of migraine
NPs and PAs
Joint Accreditation Statement
In support of improving patient care, Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hours of pharmacology credit
Nurse Planner: Susanne J. Phillips, DNP, APRN, FNP-BC, FAANP
AAPA Credit Designation
Continuing Education Alliance has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until July 23, 2020. PAs should only claim credit commensurate with the extent of their participation.
PA Planner: Daniel Thibodeau, MHP, PA-C
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity is supported by an educational grant from Allergan, Inc.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Continuing Education Alliance are required to disclose to the audience any relevant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Burch has no relevant financial relationships to disclose.
None of the members of the Planning Committee or CE Alliance staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Read the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: July 23, 2019
Expiration date: July 23, 2020
© 2020 Practicing Clinicians Exchange. All Rights Reserved. 96519AGPCE